Lv3
238 积分 2024-12-13 加入
Dermatologic adverse events caused by biologic treatments – Pathogenesis and management
16小时前
已完结
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
6天前
已完结
Real World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's Disease
10天前
已完结
Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease
10天前
已完结
Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease
10天前
已完结
Which Patients Benefit from Biologic Agents to Prevent Disease Recurrence After Resection in Crohn's Disease?
11天前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
15天前
已完结
Differentiating IL-23 Inhibitors in Crohn’s Disease
15天前
已完结
Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease
17天前
已完结
Combined Clinical and Histopathological Risk Stratification for Prediction of (severe) Endoscopic Postoperative Recurrence in Patients with Crohn’s Disease after Ileocolic Resection
29天前
已完结
皖公网安备34019202002308
